PANORAMA 2: A phase II study of panobinostat in combination with bortezomib and dexamethasone in patients with relapsed and bortezomib-refractory multiple myeloma.
Melissa Alsina
Research Funding - Celgene; Millennium
Robert L. Schlossman
No relevant relationships to disclose
Donna M. Weber
Consultant or Advisory Role - Novartis (U)
Research Funding - Novartis
Steven E. Coutre
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Sagar Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Cristina Gasparetto
Honoraria - Celgene; Millennium
Ghulam Warsi
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Michael S. Ondovik
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Sutapa Mukhopadhyay
Employment or Leadership Position - Novartis
Carole S. Paley
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Honoraria - Novartis
Paul Gerard Guy Richardson
Consultant or Advisory Role - Celgene; Johnson & Johnson; Millennium; Novartis